Trial Profile
Impact of Vaginal Estrogen in the Treatment of Symptomatic Mild Pelvic Organ Prolapse With Pelvic Floor Physical Therapy
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 13 Feb 2023
Price :
$35
*
At a glance
- Drugs Conjugated estrogens (Primary)
- Indications Pelvic floor disorders
- Focus Therapeutic Use
- 07 Feb 2023 Planned End Date changed from 1 Dec 2022 to 1 Dec 2023.
- 07 Feb 2023 Planned primary completion date changed from 1 Dec 2022 to 1 Dec 2023.
- 03 Feb 2022 Planned End Date changed from 1 Dec 2021 to 1 Dec 2022.